Compare Illumina, Inc. (ILMN) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Workday Inc — how do they compare? Illumina, Inc. trades at $265.87 (market cap $39.95B), while Workday Inc trades at $188.36 (market cap $45.26B). The key difference: Illumina, Inc. and Workday Inc are close in size by market cap, and Illumina, Inc. is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Workday Inc for 38 Days on average.
| ILMN | WDAY | |
|---|---|---|
Market Cap | $39.95B | $45.26B |
Volume | 3,169,503 | 2,342,190 |
Sector | Health | Technology |
52-Week High | $293.69 | $245.67 |
52-Week Low | $91.00 | $112.55 |
Typical Hold Time | 83 Days | 38 Days |
Enterprise Value | $41.31B | $45.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
Workday (WDAY) trades at $184.26, down 1.23% on the day, amid a broader tech selloff. The stock shows bearish technical signals with support at $182 and resistance at $187. Fundamentally, WDAY reported strong Q2 2026 EPS of $2.75, beating estimates, with revenue growth projected to reach $10.2B in 2026. Recent news includes strategic layoffs, AI product launches, and expansion in the UAE, highlighting its focus on enterprise AI solutions.
WDAY's outlook is supported by robust AI-driven revenue growth and a 50.6% analyst buy rating, with a consensus price target of $202.92 offering ~10% upside. Risks include integration costs from restructuring, competitive pressures in HR/finance software, and market volatility. The stock remains a compelling growth play if execution on AI monetization continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
